| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/19/2007 | WO2006069081A3 USE OF ANTI-Aβ ANTIBODY TO TREAT TRAUMATIC BRAIN INJURY |
| 04/19/2007 | WO2006060723A3 Methods for producing block copolymer/amphiphilic particles |
| 04/19/2007 | WO2006055697A3 Cancer immunotherapy incorporating p53 |
| 04/19/2007 | WO2006047639A3 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 04/19/2007 | WO2006041970A8 Treatment of respiratory syncytial virus (rsv) infection |
| 04/19/2007 | WO2006040153A3 Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease |
| 04/19/2007 | WO2005035712A3 Methods and compositions for infectious cdna of sars coronavirus |
| 04/19/2007 | WO2005007671A3 Compositions and methods for treating sars |
| 04/19/2007 | WO2004112694A3 Immunogenic reagents from west nile virus |
| 04/19/2007 | WO2004099375A3 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof |
| 04/19/2007 | WO2004058189A3 Chemokine antagonists and uses thereof |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088156 Recombinant viral-based malaria vaccines |
| 04/19/2007 | US20070087992 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/19/2007 | US20070087970 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087409 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/19/2007 | US20070087374 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087373 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087021 Method of protecting against chronic infections |
| 04/19/2007 | US20070087020 Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders |
| 04/19/2007 | US20070087019 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/19/2007 | US20070087018 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/19/2007 | US20070087017 Ultrafiltration for preparing outer membrane vesicles |
| 04/19/2007 | US20070087016 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/19/2007 | US20070087015 Multivalent dengue virus vaccine |
| 04/19/2007 | US20070087014 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 04/19/2007 | US20070087013 Orally-administered live bacterial vaccines for plague |
| 04/19/2007 | US20070087012 Novel therapeutic target for protozoal diseases |
| 04/19/2007 | US20070087011 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 04/19/2007 | US20070087010 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 04/19/2007 | US20070087009 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist |
| 04/19/2007 | US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 04/19/2007 | US20070087007 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/19/2007 | US20070087006 Compositions and methods for the diagnosis and treatment of tumor |
| 04/19/2007 | US20070087005 Anti-glypican-3 antibody |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070087003 Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof |
| 04/19/2007 | US20070087002 Anticholesterol immunoglobulin to treat lipid raft diseases |
| 04/19/2007 | US20070087001 phage display; fusion proteins; kits; immunohistochemistry |
| 04/19/2007 | US20070087000 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 04/19/2007 | US20070086999 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 04/19/2007 | US20070086998 Therapeutic human anti-mhc class II antibodies and their uses |
| 04/19/2007 | US20070086997 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 04/19/2007 | US20070086996 Biodegradable T-cell activation device and methods |
| 04/19/2007 | US20070086995 Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations |
| 04/19/2007 | US20070086994 Anti-nik antibodies and uses thereof |
| 04/19/2007 | US20070086992 stimulating antitumor immune responses; tissue-targeted therapy; first tumour antigen is used to treat secondary tumor; biodrug for cancer immunotherapy with cyclophosphamide |
| 04/19/2007 | US20070086991 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 04/19/2007 | US20070086985 Vectors for tissue-specific replication |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | US20070086983 Endothelium-targeting nanoparticle for reversing endothelial dysfunction |
| 04/19/2007 | US20070086979 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 04/19/2007 | US20070086950 GAT2 transporters expressed in blood brain barrier cells |
| 04/19/2007 | US20070086943 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy |
| 04/19/2007 | CA2639119A1 Agent for preventing/treating cancer |
| 04/19/2007 | CA2625998A1 Optimized anti-cd30 antibodies |
| 04/19/2007 | CA2625773A1 Inhibition of interleukin-6 (il-6) receptor promotes pancreatic islet transplantation |
| 04/19/2007 | CA2625506A1 Immuno-stimulant combination for prophylaxis and treatment of hepatitis c |
| 04/19/2007 | CA2625440A1 Compositions comprising cross-species-specific antibodies and uses thereof |
| 04/19/2007 | CA2625349A1 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 04/19/2007 | CA2625293A1 Fusion proteins for blood-brain barrier delivery |
| 04/19/2007 | CA2624976A1 Anti-myostatin antibodies |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2624559A1 Optimal polyvalent vaccine for cancer |
| 04/19/2007 | CA2623531A1 Matrix metalloproteinase 11 vaccine |
| 04/19/2007 | CA2623109A1 Compositions and methods for treating proliferative disorders |
| 04/19/2007 | CA2622464A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | CA2621320A1 Vaccines and methods to treat canine influenza |
| 04/18/2007 | EP1775343A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 04/18/2007 | EP1775342A1 Anticancer agent containing minus-strand rna virus |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1775000A2 Method of producing universal blood plasma from blood |
| 04/18/2007 | EP1774977A2 Genetically engineered bleb vaccine |
| 04/18/2007 | EP1774332A2 Immune response assessment method |
| 04/18/2007 | EP1774329A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/18/2007 | EP1774326A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/18/2007 | EP1774037A2 Assays and methods using biomarkers |
| 04/18/2007 | EP1774031A2 Cancer treatment method by inhibiting mage gene expression or function |
| 04/18/2007 | EP1774012A2 Immune modulating compounds from fungi |
| 04/18/2007 | EP1773999A2 Vaccine for prevention and treatment of hiv-infection |
| 04/18/2007 | EP1773990A2 Capsules containing transfected cells, method for preparing the same and use thereof for immunization and vaccination |
| 04/18/2007 | EP1773988A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/18/2007 | EP1773885A2 Humanized anti-cmet antagonists |
| 04/18/2007 | EP1773882A2 Diagnosis and treatment of siglec-6 associated diseases |
| 04/18/2007 | EP1773881A2 Inhibition of macrophage-stimulating protein receptor (ron) |
| 04/18/2007 | EP1773880A2 Env polypeptide complexes and methods of use |
| 04/18/2007 | EP1773876A1 Hpv vaccine comprising peptides from host cell proteins |
| 04/18/2007 | EP1773873A2 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 04/18/2007 | EP1773858A2 Cynomolgus prostate specific antigen |
| 04/18/2007 | EP1773403A2 Viral adjuvants |
| 04/18/2007 | EP1773402A2 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/18/2007 | EP1773394A2 Antagonizing interleukin-21 receptor activity |
| 04/18/2007 | EP1773393A2 Preventing autoimmune disease by using an anti-cd20 antibody |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773391A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 04/18/2007 | EP1773390A2 Improved therapeutic agent for inos generating illness |
| 04/18/2007 | EP1773389A2 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1 |
| 04/18/2007 | EP1773388A2 Sars vaccines and methods to produce highly potent antibodies |